57
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Association between urinary fluoride concentrations and the prevalence of metabolic syndrome in adult individuals from the Central Region of Mexico

, , &
Received 04 Sep 2023, Accepted 26 Oct 2023, Published online: 06 Nov 2023

References

  • Ab-Hamid N, Omar N, Ismail CAN, Long I. 2023. Diabetes and cognitive decline: Challenges and future direction. World J Diabetes. 14(6):795–807. doi: 10.4239/wjd.v14.i6.795.
  • Aylward LL, Hays SM, Vezina A, Deveau M, St-Amand A, Nong A. 2015. Biomonitoring equivalents for interpretation of urinary fluoride. Regul Toxicol Pharmacol. 72(1):158–167. Internet. doi: 10.1016/j.yrtph.2015.04.005.
  • Ballantyne JA, Coyle G, Sarwar S, Kühn T. 2022. Fluoride status and cardiometabolic health: findings from a representative Survey among children and adolescents. Nutrients. 14(7):1459. doi: 10.3390/nu14071459.
  • Behl TA, Stamford BA, Moffatt RJ. 2022. The effects of smoking on the diagnostic characteristics of metabolic syndrome: a review. Am J Lifestyle Med. 17(3):397–412. [Internet]. doi: 10.1177/15598276221111046.
  • Belete R, Ataro Z, Abdu A, Sheleme M. 2021. Global prevalence of metabolic syndrome among patients with type I diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 13(1):25. [Internet]. doi:10.1186/s13098-021-00641-8.
  • Dobrowolski P, Prejbisz A, Kurylowicz A, Baska A, Burchardt P, Chlebus K, Dzida G, Jankowski P, Jaroszewicz J, Jaworski P, et al. 2022. Metabolic syndrome a new definition and management guidelines. Arch Med Sci. 18(5):1133–1156. doi:10.5114/aoms/152921.
  • Fahed G, Aoun L, Zerdan Morgan B, Allam S, Zerdan Maroun B, Bouferraa Y, Assi HI. 2022. Metabolic syndrome: updates on pathophysiology and management in 2021. IJMS. 23(2):786. [Internet]. doi: 10.3390/ijms23020786.
  • Fernández-Macias JC, Ochoa-Martínez ÁC, Orta-García ST, Varela-Silva JA, Pérez-Maldonado IN. 2020. Probabilistic human health risk assessment associated with fluoride and arsenic co-occurrence in drinking water from the metropolitan area of San Luis Potosí, Mexico. Environ Monit Assess. 192(11). doi:10.1007/s10661-020-08675-7
  • Hiramatsu Y, Ide H, Furui Y. 2023. Differences in the components of metabolic syndrome by age and sex: a cross-sectional and longitudinal analysis of a cohort of middle-aged and older Japanese adults. BMC Geriatr. 23(1):438. doi: 10.1186/s12877-023-04145-0.
  • Hirode G, Wong RJ. 2020. Trends in the prevalence of metabolic syndrome in the United States, 2011-2016. JAMA. 323(24):2526–2528. [Internet]. doi:10.1001/jama.2020.4501.
  • Hoveling LA, Lepe A, Boissonneault M, de Beer JAA, Smidt N, de Kroon MLA, Liefbroer AC. 2023. Educational inequalities in metabolic syndrome prevalence, timing, and duration amongst adults over the life course: a microsimulation analysis based on the lifelines cohort study. Int J Behav Nutr Phys Act. 20(1):104. [Internet]. doi:10.1186/s12966-023-01495-1.
  • Itai K, Onoda T, Nohara M, Kuribayashi T, Tanno K, Ohsawa M, Mori M, Okayama A. 2021. Slightly elevated serum ionic fluoride levels inhibit insulin secretion and increase glucose levels in a general Japanese population: a cross-sectional Study. Biol Trace Elem Res. 199(8):2819–2825. [Internet]. doi:10.1007/s12011-020-02415-1.
  • Katsi V, Papakonstantinou I, Tsioufis K. 2023. Atherosclerosis, diabetes mellitus, and cancer: common epidemiology, shared mechanisms, and future management. Int J Mol Sci. 24(14):11786. doi: 10.3390/ijms241411786.
  • Kumar S, Senapati S, Bhattacharya N, Bhattacharya A, Maurya SK, Husain H, Bhatti JS, Pandey AK. 2023. Mechanism and recent updates on insulin-related disorders. World J Clin Cases. 11(25):5840–5856. Internet. doi:10.12998/wjcc.v11.i25.5840.
  • Lepe A, de Kroon MLA, Reijneveld SA, de Winter AF. 2023. Socioeconomic inequalities in paediatric metabolic syndrome: mediation by parental health literacy. Eur J Public Health. 33(2):179–183. [Internet]. doi:10.1093/eurpub/ckad028.
  • Li M, Zhao Y, Tian X, Liu P, Xie J, Dong N, Feng J, Gao Y, Fan Y, Qiu Y, et al. 2021. Fluoride exposure and blood pressure: a systematic review and meta-analysis. Biol Trace Elem Res. 199(3):925–934. Internet. doi:10.1007/s12011-020-02232-6.
  • McCarthy K, Laird E, O’Halloran AM, Fallon P, O’Connor D, Ortuño RR, Kenny RA, Xie L. 2022. An examination of the prevalence of metabolic syndrome in older adults in Ireland: findings from the Irish longitudinal study on ageing (TILDA). PloS One. 17(9):e0273948–. [Internet]. doi: 10.1371/journal.pone.0273948.
  • Morales-Arredondo JI, Armienta-Hernández MA, Lugo-Dorantes AE, Barrera-Arrazola AP, Flores-Ocampo IZ, Flores-Vargas R. 2023. Fluoride presence in drinking water along the southeastern part of El Bajío Guanajuatense, Guanajuato, Mexico: sources and health effects. Environ Geochem Health. 45(6):3715–3742. [Internet]. doi:10.1007/s10653-022-01426-2.
  • Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck JR, Nyaga UF, Ngouo AT, Tounouga DN, Tianyi FL, Foka AJ, Ndoadoumgue AL, et al. 2022. Global, regional, and country estimates of metabolic syndrome burden in children and adolescents in 2020: a systematic review and modelling analysis. Lancet Child Adolesc Health. 6(3):158–170. Internet. doi: 10.1016/S2352-4642(21)00374-6.
  • Ochoa-Martínez ÁC, Araiza-Gamboa Y, Varela-Silva JA, Orta-García ST, Carrizales-Yáñez L, Pérez-Maldonado IN. 2021. Effect of gene-environment interaction (arsenic exposure - PON1 Q192R polymorphism) on cardiovascular disease biomarkers in Mexican population. Environ Toxicol Pharmacol. 81:103519. doi: 10.1016/j.etap.2020.103519.
  • Ortiz-Letechipia J, González-Trinidad J, Júnez-Ferreira HE, Bautista-Capetillo C, Dávila-Hernández S. 2021. Evaluation of groundwater quality for human consumption and irrigation in relation to arsenic concentration in flow systems in a semi-arid Mexican region. Int J Environ Res Public Health. 18(15):8045. doi: 10.3390/ijerph18158045.
  • Pal P, Jha NK, Pal D, Jha SK, Anand U, Gopalakrishnan AV, Dey A, Mukhopadhyay PK. 2023. Molecular basis of fluoride toxicities: beyond benefits and implications in human disorders. Genes Dis. 10(4):1470–1493. doi: 10.1016/j.gendis.2022.09.004.
  • Palmer MK, Toth PP. 2019. Trends in lipids, obesity, metabolic syndrome, and diabetes mellitus in the United States: an NHANES analysis (2003-2004 to 2013-2014). Obesity. 27(2):309–314. [Internet]. doi: 10.1002/oby.22370.
  • Pánico P, Velasco M, Salazar AM, Picones A, Ortiz-Huidobro RI, Guerrero-Palomo G, Salgado-Bernabé ME, Ostrosky-Wegman P, Hiriart M. 2022. Is arsenic exposure a risk factor for metabolic syndrome? A review of the potential mechanisms. Front Endocrinol (Lausanne). 13: [Internet]. doi:10.3389/fendo.2022.878280.
  • Pinheiro LCHT, Rossi M, dos Santos CAF, Oliveira LVF, Vencio S, de Paula Vieira R, Juliano Y, Armond J, Silva CHM, Fonseca AL, et al. 2023. Prevalence of associations among sarcopenia, obesity, and metabolic syndrome in Brazilian older adults. Front Med. [Internet]. 10. 10.3389/fmed.2023.1206545.
  • Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills AP, Misra A. 2017. Prevalence and trends of metabolic syndrome among adults in the Asia-pacific region: a systematic review. BMC Public Health. 17(1):101. [Internet]. doi:10.1186/s12889-017-4041-1.
  • Rojas-Martínez R, Aguilar-Salinas CA, Romero-Martínez M, Castro-Porras L, Gómez-Velasco D, Mehta R. 2021. Trends in the prevalence of metabolic syndrome and its components in Mexican adults, 2006-2018. Salud Publica Mex. 63(6, Nov–Dic):713–724. doi: 10.21149/12835.
  • Ruiz-Vera T, Ochoa-Martínez ÁC, Pruneda-Álvarez LG, Domínguez-Cortinas G, Pérez-Maldonado IN. 2019. Expression levels of circulating microRnas-126, -155, and -145 in Mexican women exposed to polycyclic aromatic hydrocarbons through biomass fuel use. Environ And Mol Mutagen. 60(6):546–558. doi: 10.1002/em.22273.
  • Saif-Ali R, Kamaruddin NA, Al-Habori M, Al-Dubai SA, Ngah WZW. 2020. Relationship of metabolic syndrome defined by IDF or revised NCEP ATP III with glycemic control among Malaysians with type 2 diabetes. Diabetol Metab Syndr. 12(1). doi:10.1186/s13098-020-00575-7
  • Schneider-Matyka D, Gutowska I, Panczyk M, Grochans E, Szkup M. 2021. Elevated serum fluoride levels in perimenopausal women are related to the components of metabolic syndrome. [place unknown].
  • Shrivastava S, Singh K, Chakma T, Kavishwar A. 2023. Metabolic syndrome in Indian tribes: challenges to reveal its true status. Front Clin Diabetes Healthc. 4. [Internet]. doi: 10.3389/fcdhc.2023.1194471.
  • Sun K, Liu J, Ning G, Barengo NC. 2012. Active smoking and risk of metabolic syndrome: a meta-analysis of prospective studies. PloS One. 7(10):e47791–. [Internet]. doi: 10.1371/journal.pone.0047791.
  • Vajravelu ME, Tas E, Arslanian S. 2023. Pediatric obesity: complications and Current day management. Life. 13(7):1591. doi: 10.3390/life13071591.
  • Zepeda-Zepeda MA, Picquart M, Irigoyen-Camacho ME, Mejía-Gózalez AM. 2021. Diagnosis of dental fluorosis using micro-raman spectroscopy applying a principal component-linear discriminant analysis. Int J Environ Res Public Health. 18(20):10572. doi: 10.3390/ijerph182010572.
  • Zuo H, Chen L, Kong M, Qiu L, P L, Wu P, Yang Y, Chen K. 2018. Toxic effects of fluoride on organisms. Life Sci. 198:18–24. Internet. doi: 10.1016/j.lfs.2018.02.001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.